VTRS

Viatris Inc Ord Shs

• Seeking Alpha·1d ago

  Notable healthcare headlines for the week: J&J, Abbott and Organon in focus

• Dow Jones·3d ago

  Viatris Inc. Stock Advances 4.8%, Outperforms Market

• MarketWatch·3d ago

  Viatris Inc. stock rises Friday, outperforms market

• Seeking Alpha·4d ago

  The 10 Healthcare stocks with the lowest forward P/E ratios

• Benzinga·4d ago

  FDA Takes Step Forward on Testosterone Therapy for Men

• Benzinga·5d ago

  Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

• Simply Wall St·6d ago

  Viatris Ophthalmology Data At ASCRS Puts Valuation And Dividend In Focus

• Seeking Alpha·6d ago

  Quant check on David Einhorn's Greenlight Capital holdings post Q1

• Reuters·04/13 19:18

  Teva must face Mylan lawsuit over generic competition for Copaxone

• PUBT·04/13 10:59

  Viatris to report first-quarter results, host webcast call

• PR Newswire·04/13 10:59

  Viatris to Report First Quarter 2026 Financial Results on May 7, 2026

• TipRanks·04/13 09:17

  Barclays Keeps Their Buy Rating on Viatris (VTRS)

• Simply Wall St·04/11 15:16

  Assessing Viatris (VTRS) Valuation After A Recent Share Price Pullback

• Reuters·04/10 10:59

  Viatris to present Phase 3 MR-141 presbyopia trial data at ASCRS meeting

• PR Newswire·04/10 10:59

  Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting